In a regulatory filing, Vertex Pharmaceuticals (VRTX) chief scientific officer David Altshuler disclosed the sale of 3,231 common shares of the company on March 13 at a price of $510 per share.
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...
The Morgan County Sheriff's Office say a wreck on Highway 231 at Old Highway 231 in Lacey's Spring caused traffic to be rerouted Friday night. The sheriff's office said shortly after 7:30 p.m ...
Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals ... “In the interim, Journavx was added to our standard commercial ...